Digestive Health

People have been taking probiotics to support digestive health for centuries, but researchers in the pulmonary field have turned their attention toward how microbiome science can be used to support the lungs.

Risankizumab-rzaa (Skyrizi) is the first and only specific interleukin-23 inhibitor approved for the treatment of adults with moderately to severely active Crohn disease.

These results from 3 separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with ustekinumab (Stelara) were presented at Digestive Disease Week meeting in San Diego, California.

IBS Complete Support helps relieve abdominal pain, bloating, and constipation associated with irritable bowel syndrome.

Pepcid is indicated in adult and pediatric patients 40 kg and above for the treatment of active duodenal ulcer active gastric ulcer.

Gastro-Ease helps maintain a healthy stomach, promoting health and comfort.

The drug is a treatment for individuals who are healing all grades of erosive esophagitis, as a relief of heartburn, and as maintenance of healing all grades of EE and relief of heartburn.

Any antibiotic use was associated with higher rates of IBD, and the risk went up substantially with each course.

Linaclotide (Linzess) is indicated in adults for treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

Beat the Bloat helps reduce belly bloat caused by digestion woes, gas, and water retention.

Be aware of products containing gluten, nonsteroidal anti-inflammatory drugs, and olmesartan.

Docusate treats occasional constipation by reducing surface tension and emulsification of fecal matter, which allows water to penetrate and mix with and soften stool.

Obeticholic acid (Ocaliva) is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.

Phazyme is used to treat symptoms of gas, such as belching, bloating, and pressure in the stomach/gut.

A significantly greater proportion or patients treated with either 15 or 30 mg show remission or endoscopic response or remission at week 52 compared with the placebo.

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis.

Vedolizumab (Entyvio) is indicated for adult patients with moderately to severely active ulcerative colitis and adult patients with moderately to severely active Crohn disease.

Oxy-Powder is designed to clean the digestive tract and oxidize and decrease the amount of impacted fecal matter.

The Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) were previously granted priority review designation by the FDA for H. pylori infection.

Prunelax is a laxative made of natural Senna leaves to relieve occasional constipation.

Pedialyte replaces fluids, electrolytes, and minerals lost from diarrhea and vomiting.

Alka-Seltzer relieves heartburn, upset stomach, and acid indigestion.

Kaopectate treats diarrhea, heartburn, nausea, and upset stomach.

Zantac can treat and prevent heartburn, as well as treating stomach ulcers, gastroesophageal reflux disease, and conditions that cause too much stomach acid.

Bismuth subsalicylate is indicated for heartburn, indigestion, and upset stomach.